Chemocentryx (CCXI) Posts Q2 Loss of 30c/Share, Misses Views
Tweet Send to a FriendGet Alerts CCXI Hot Sheet
Trade CCXI Now!
Chemocentryx (NASDAQ: CCXI) reported Q2 EPS of ($0.30), $0.09 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $1.13 million versus the consensus estimate of $4.75 million.
For earnings history and earnings-related data on Chemocentryx (CCXI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Chemocentryx (CCXI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Leading Brands Inc New (LBIX) Reports Breakeven Q4 Loss
- Chemocentryx (CCXI) Posts Q1 Loss of 28c/Share
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
